WebJul 23, 2011 · Guidance. This guideline covers managing stable angina in people aged 18 and over. It outlines the importance of addressing the person’s concerns about stable angina and the roles of medical therapy and revascularisation. Diagnosing stable angina is covered in NICE’s guideline on chest pain of recent onset: assessment and diagnosis. WebFor women aged under 55 years — consider referring urgently using a suspected cancer pathway for an appointment within 2 weeks. She is pregnant and has significant symptoms and/or severe anaemia (haemoglobin less than 70 g/L), or late gestation (over 34 weeks), or if there is failure to respond to a trial of oral iron. Also refer people:
Referral Guidelines - NHSGGC
WebIf evidence of ascites and peripheral oedema give. Human Albumin Solution (HAS) Day 1: HAS 20% IV 100ml, 1g/kg (usually 2-5 bottles) or HAS 5% IV 500ml 1.5g/kg (usually 2-4 bottles) Day 2-16: HAS 20% IV 100ml or HAS 5% 500ml 1-2 bottles per day and consider: Terlipressin IV – initially 0.5-2mg every 4 hours. WebThe care pathways for the emergency management of DKA should be used for all eligible patients. Complete pathways for 0–4 hours and 4 hours–discharge for each DKA … trad4u_online
GGC Medicines - Iron Deficiency Anaemia in Acute Care
WebJan 11, 2024 · Authors: Maddox TM, Januzzi JL Jr, Allen LA, et al. Citation: 2024 Update to the 2024 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight … WebAbout the Global Heart Failure Academy. This truly global curriculum was developed by world-renowned leaders in the management of heart failure and is dedicated to … WebAug 25, 2024 · This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with CKD. In November 2024, we updated our guidance … trad\u0027azun